Carva®

Aspirin
Anti-platelet Agents (Cardiovascular Preparations)

Indication:

Antithrombotic action, mediated through inhibition of platelet activation, secondary prophylaxis following myocardial infarction and unstable angina or cerebral transient ischemic attacks.

Dosage & Administration:

150 mg at diagnosis and 75 mg daily thereafter.

Preparation:

Carva^® 75 tablet: Box containing 20 x 10 tablets in strip pack.